ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
University of Milan
Milán, ItaliaPublicaciones en colaboración con investigadores/as de University of Milan (3)
2023
-
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
The Lancet, Vol. 402, Núm. 10395, pp. 41-53
-
Health-related quality of life (HRQoL) associated with fruquintinib in the global phase 3, placebo-controlled, double-blind FRESCO-2 study.
Journal of Clinical Oncology
2018
-
Dynamic molecular analysis and clinical correlates of tumor evolution within a phase II trial of panitumumab-based therapy in metastatic colorectal cancer
Annals of Oncology, Vol. 29, Núm. 1, pp. 119-126